BIO-Asia Partnering Conference 2008

The Biotechnology Industry Organization (BIO) is proud to announce the fifth annual BIO-Asia Partnering Conference, January 28-29, 2008, in Tokyo, Japan. This exclusive, customized partnering forum brings together biotechnology and pharmaceutical companies from North America, Europe and the Asia Pacific region to explore doing business together. In 2007, BIO-Asia attracted participants representing 271 companies from 25 countries.

The conference format features private, pre-arranged one-on-one meetings between senior-level executives and is an unrivalled opportunity to meet with the leading international pharmaceutical and biotech companies in one place at one time.

BIO brings more than ten years of experience and expertise in biotech and pharmaceutical partnering to the Asia-Pacific region, after successfully establishing the largest partnering-focused events in the U.S. and Europe.

The BIO-Asia Partnering Conference 2008 is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements.

The conference features private, pre-arranged one-on-one meetings between senior-level executives, using BIO’s proprietary, state-of-the-art computer software. The format and selective nature of the conference makes this the premier dedicated biotech partnering event in Asia and an unrivalled opportunity to meet with the leading international pharmaceutical and biotech companies in one place at one time.

BIO-Asia’s benefits include:

Access to senior-level executives from leading international pharmaceutical & biotechnology companies
Exposure to new and exciting companies ready for partnerships and licensing opportunities in the U.S., Europe and Asia
Tremendous networking opportunities to meet numerous U.S., European, Japanese and Asian biotech and pharmaceutical companies in one place at one time
Use of state-of-the-art partnering technology
Exclusivity
Targeted partner selections through proprietary screening process
Private meetings scheduled by BIO
Informative plenary sessions
We recommend that your company have projects in the below disease areas and is seeking partnerships and licensing collaborations in the U.S./Europe or in Asia.

Recommended Disease Categories

Autoimmune and Inflammation (anti-inflammatory, allergic diseases)
Blood and Lymphatic System (hyperlipemia)
Cancer (hairy cell leukemia, prostate cancer, major organ cancers)
Cardiovascular & Circulatory System (cardiovascular disease, acute coronary syndromes, hypertension, atherosclerosis, hypercholesterolemia)
CNS Disorders (Alzheimer's disease, depression, anxiety, stroke, Parkinson’s disease, schizophrenia)
Digestive System (liver diseases, gastrointestinal disorders)
Infections (hepatitis C, fungal)
Kidneys and Genito-Urinary System (incontinence, urogenital diseases, gynecology, benign prostatic hyperplasia, renal failure)
Metabolic Disorders (diabetes [II], diabetes complications/mellitus, obesity)
Musculo-Skeletal Disorders (arthritis, osteoarthritis, rheumatoid arthritis [chronic], osteoporosis, Sjogren's syndrome, bone/joint diseases, orthopedics)
Non-narcotic pain management
Respiratory & Pulmonary System (influenza, asthma)

Contact: Biotechnology Industry Organization (BIO)
Tel: +212-332-4355
Email: [email protected]
URL: http://bioasia.bio.org/opencms/bioasia/2008/index.jsp